Adult Non-Hodgkin Lymphoma — Trials

Adult Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 21%
Top sponsor: City of Hope Medical Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (49)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05186012	APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma	unknown	Phase 1 / Phase 2	51	Ascentage Pharma Group Inc.INDUSTRY	1	Jan 23, 2024	clinicaltrials
NCT02481310	Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma	unknown	Phase 1 / Phase 2	38	Northwestern UniversityOTHER	1	Feb 21, 2022	clinicaltrials